about
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderA high throughput in vivo assay for taste quality and palatabilityIn Vitro and In Vivo Characterization of the Alkaloid NuciferineMonoamine transporter inhibitors and substrates as treatments for stimulant abuseEvaluation of animal models of neurobehavioral disorders.A stimulus-control account of dysregulated drug intake.Animal models of cannabinoid reward.Drug addiction.The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout miceN-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gasNeuropharmacology of the interoceptive stimulus properties of nicotine.Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats.Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal womenBehavioral and toxicological effects of propofol.Testosterone as a discriminative stimulus in male rats.Predictive validity of behavioural animal models for chronic painGABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vaporClinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons.Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysisEffects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and miceEndocannabinoid system involvement in brain reward processes related to drug abuseAssessment of the interoceptive effects of alcohol in rats using short-term training procedures.Discrimination of ethanol-nicotine drug mixtures in mice: dual interactive mechanisms of overshadowing and potentiation.Dopamine D3 receptor ligands for the treatment of tobacco dependence.Overlapping, but not identical, discriminative stimulus effects of the neuroactive steroid pregnanolone and ethanolCharacterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.The impact of early environmental rearing condition on the discriminative stimulus effects and Fos expression induced by cocaine in adult male and female ratsBlocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studiesEffects of nicotine in experimental animals and humans: an update on addictive propertiesA stimulus-control account of regulated drug intake in ratsA within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeysInhaled toluene vapor as a discriminative stimulusCharacterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration.Benzodiazepine-like discriminative stimulus effects of toluene vapor.Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.Human drug discrimination: A primer and methodological reviewHuman Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.
P2860
Q27015917-A6AC349A-C657-44C1-9630-7DCF935EBD09Q27308945-71626345-858D-4F06-A2AF-A241ACFAB3FAQ28550683-55C2657A-D716-48C3-8B68-7FF0C9AA9AB7Q30413718-D6EC49DF-8859-49F4-A747-5AE8DF310AB7Q30490127-558D28BF-5650-4A88-B2C8-5DC21C11BD90Q34066993-05CF7F65-F6B9-498A-B91C-9949CF4C8C31Q34098204-E80C5CC2-8801-4448-9BCB-B7663152FB3EQ34575484-0B6B0E94-294A-4579-B238-57D300E32481Q34766609-257B0C53-21B1-4536-8947-68450A9C0C20Q34785557-5F7D5AFC-B67B-4F3D-90B2-13E47DE706EEQ34906263-0D82BAA4-3385-4427-A3EE-9F15461CB17BQ35091452-EAE12110-CE52-4E5E-B7B3-42FDB9ABF389Q35212010-2F5C9028-0981-4580-9347-484FF9C62E10Q35218366-C37324D7-8CCC-45CF-B0B0-0FFEF12D6A50Q35242036-8DCD752F-A3AF-4B96-8A81-B3DD87D0EF63Q35589944-8765EB5C-B9A1-4768-A31C-296458A9CB74Q35670267-4E187319-0C34-4B4D-A791-3A03AD329E04Q35684589-E791F1FE-C23B-4A3F-8B36-959F002C818DQ35913130-5D626726-56DB-4055-8A60-8119ED283DE3Q36130597-34D425F2-5D58-4E28-88E3-9F0DAAAC2106Q36298187-4F96A481-FEDF-440E-B9BD-538E11F8A5CAQ36357182-3FF0C69D-1707-4DFD-9370-97E97095A33EQ36395109-2FDAECDA-5C67-4FA3-8821-964B89ACEEEAQ36395112-350133A7-8E29-44DB-A735-188BF0E1CB5FQ36677397-518DC99A-F1AA-4759-9777-B0B6A8132A8FQ36726796-5CE0B621-E2A6-4CA3-B7B7-A099D2B4A77EQ36733530-C670DDB1-E645-4B10-B825-9849D029E4F7Q37142046-322B9456-B816-4E7B-A116-978BE36B19A3Q37164812-B9F234B7-7AB4-4385-A586-B901B5BFC73AQ37203879-B7BA8318-BBAB-418F-9B5E-D8F0CFC225DAQ37236393-BFCF050B-25CD-4414-AEF7-DE4A1B23169BQ37335562-C136EE17-C82C-4D05-808A-8D141B182B6DQ37449776-0C0FF312-540E-49E4-8491-EA5F83E270F2Q37465327-33E4BD74-9CF2-4762-9EEE-0593C3C30FEAQ37603440-5B7448EC-C7BC-4C17-B6DB-426C1C9E97F1Q37625769-46E67135-DD95-49C2-9F68-C8516F424D0AQ38190472-3FEF1AE2-5844-4969-8529-45B40983273BQ38838176-07BC4052-7BC7-47AC-8311-3F4A8376DDF6Q38856900-218E4A20-41B2-46FE-8B29-1B3F645502B3Q38862468-7341A45E-57B2-4217-BAAE-128203E5175C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Drug discrimination in neurobiology.
@ast
Drug discrimination in neurobiology.
@en
type
label
Drug discrimination in neurobiology.
@ast
Drug discrimination in neurobiology.
@en
prefLabel
Drug discrimination in neurobiology.
@ast
Drug discrimination in neurobiology.
@en
P1476
Drug discrimination in neurobiology.
@en
P2093
Colpaert FC
P304
P356
10.1016/S0091-3057(99)00047-7
P407
P577
1999-10-01T00:00:00Z